Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis
- 18 February 2022
- journal article
- research article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 29 (5) , 552-561
Abstract
Background: Although distant metastasis from pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, some single center studies reported that lung metastasis has a favorable prognosis. The aim of this study is to evaluate the prognostic value of site‐specific metastasis after pancreatectomy for PDAC, with a focus on lung metastasis.Methods: Data from 117 cases of lung metastasis after pancreatectomy were collected retrospectively from 23 institutions in Japan. To compare the sites of metastasis we also collected the data of 134 patients with liver only metastasis, 67 patients with peritoneal only metastasis and 121 patients with locoregional recurrence alone.Results: In patients with lung only metastasis, the median time from recurrence to death (RTD) was 23.1 months, which was better in comparison to other sites of recurrence. In lung metastasis group, the patients who underwent pulmonary resection had better long‐term outcomes in comparison to those who did not. (RTD: 29.2 vs 15.2, P < .001). In the multivariate analysis, solitary metastasis (HR 5.03; 95% CI 1.195‐21.144, P = .022) and postoperative chemotherapy (HR 14.089; 95% CI 1.729‐114.77, P = .023) were identified as significant prognostic factors after lung resection.Conclusions: Surgical resection is a favorable option for selected patients with a solitary lung metastasis and for whom adjuvant chemotherapy can be administrated.Keywords
This publication has 23 references indexed in Scilit:
- Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patternsOncotarget, 2015
- The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreasJournal of Surgical Oncology, 2015
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Loss of SMAD4 staining in pre-operative cell blocks is associated with distant metastases following pancreaticoduodenectomy with venous resection for pancreatic cancerJournal of Surgical Oncology, 2014
- Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal AdenocarcinomaAnnals of Surgical Oncology, 2013
- Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic ResectionJournal of Gastrointestinal Surgery, 2012
- Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and SurvivalJournal of Gastrointestinal Surgery, 2011
- The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Patterns of recurrence after curative resection of pancreatic ductal adenocarcinomaEuropean Journal of Surgical Oncology, 2009
- Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinomaLangenbeck's Archives of Surgery, 2008